Basic Study on Gastro-Intestinal Toxicity Caused by Macrolide Antibiotics.

Accession number;01A0773152
Title;Basic Study on Gastro-Intestinal Toxicity Caused by Macrolide Antibiotics.
Author; TOKUNAGA JIN (Kumamotodai I Byoin Yakuzaibu) OKAMURA KEIKO (Kumamotodai I Byoin Yakuzaibu) HAMADA AKINOBU (Kumamotodai I Byoin Yakuzaibu) SHIRAKI NOBUAKI (Kumamotodai I Byoin Yakuzaibu) MIYAMOTO SHINJI (Kumamotodai I Byoin Yakuzaibu) FUJII JUNKO (Kumamotodai I Byoin Yakuzaibu) ARIMORI KAZUHIKO (Miyazakidai I Byoin Yakuzaibu) NAKANO MASAHIRO (Kumamotodai I Byoin Yakuzaibu)
Journal Title;Japanese Journal of Pharmaceutical Health Care and Sciences
Journal Code:Y0888A
ISSN:1346-342X
VOL.27;NO.4;PAGE.351-355(2001)
Figure&Table&Reference;FIG.4, REF.15
Pub. Country;Japan
Language;Japanese
Abstract;We investigated the cytotoxicity of erythromycin stearate, roxithromycin, clarithromycin and minocycline using lactate dehydrogenase (LDH) in cultured human intestinal epithelial cells Caco-2, in vitro, and rat intestinal enzymes LDH and alkaline phosphatase (ALP) as end points of toxicity, in viro. The cytotoxicity after the addition of roxithromycin and clarithromycin to the Caco-2 cells tended to be larger than that after the addition of erythromycin and minocycline. The intestinal toxicity induced by repeated 5-day orally administered macrolide antibiotics was examined. The reduction in intestinal ALP after the administration of erythromycin and clarithromycin to rats tended to be larger than that after the addition of roxithromycin and minocycline. However, there were no significant changes in the intestinal LDH when macrolide antibiotics were orally administered. In addition, there were no significant changes or differences in either the body weight gain or the histological findings of the rat intestine. These results do not suggest any substantial risk for intestinal disorders related to the use of erythromycin, clarithromycin and roxithromycin. (author abst.)